HIV Prevention Trials Network
HIV Prevention Trials Network
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Characterization of Doxycycline Pharmacokinetics and Adherence | Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, infectious disease, sexually transmitted disease | Enrolling by invitation | Phase 1 | 2026-09-17 | NCT07755618 | |
| Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) | Pre-Exposure Prophylaxis of HIV Infection | Active, not recruiting | Phase 2 | 2026-08-17 | NCT06101329 | |
| Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) | Pre-Exposure Prophylaxis of HIV Infection | Active, not recruiting | Phase 2 | 2026-08-13 | NCT06101342 | |
| Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy | AIDS, Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Genital Diseases, HIV infectious disease, Hepadnaviridae infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, hepatitis, hepatitis B virus infection, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, liver disorder, sexually transmitted disease, uterine carcinosarcoma, viral hepatitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 3 | 2026-06-22 | NCT07658976 | |
| Getting to Zero Among HHI MSM in the American South | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Enrolling by invitation | Not applicable | 2026-03-13 | NCT05075967 | |
| Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 2 | 2026-02-19 | NCT07288190 |